Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Multimodal Digital Biomarkers for Evidence-Based Mental Health Decision Support and Monitoring

Objectif

AIREST (Artificial-Intelligence-based Rapid Emotional Screening Test) is an AI-driven Software as a Medical Device (SaMD) in development that uses modern AI and machine-learning methods to analyse multimodal behavioural biomarkers from short voice-and-video interactions. It combines acoustic and linguistic features of speech, vocal prosody, facial-expression dynamics and simple attention-related measures into objective, quantitative indicators of mental health.The system is intended for early detection, standardised screening and diagnostic support for mental health conditions, including depressive episodes and recurrent depressive disorder, generalised anxiety disorder, mixed anxiety and depressive disorder and post-traumatic stress disorder (PTSD). By processing a few minutes of guided interaction, AIREST generates risk scores and trend indicators that can be integrated into existing clinical workflows and electronic health records.

Champ scientifique (EuroSciVoc)

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-EIC - HORIZON EIC Grants

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) HORIZON-EIC-2025-UKRAINIANTECH-01

Voir tous les projets financés au titre de cet appel

Coordinateur

LIMITED LIABILITY COMPANY AIREST
Contribution nette de l'UE
€ 494 964,38
Adresse
HRYSHKA MYKHAILA ST 4 OFFICE 10/1
02072 KYIV
Ukraine
PME
Oui
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Liens
Coût total
Aucune donnée